Tag Archives: Oxford covid 19 vaccine

The world’s largest vaccination campaign against the new coronavirus will begin on Saturday when India begins vaccinating three million million of its front-line workers. In the first phase, two indigenous vaccines, Covaxin and Covishield, will be administered to the priority groups. More than one crore and 5.27 lakh people have …

The indigenous vaccine developed by Bharat Biotech with the Indian Council for Medical Research (ICMR) will be used as a ‘backup’, only if the country needs additional doses to vaccinate large numbers of people, particularly given the possibility of an increase sudden triggered by the UK variant. And, unlike the …

The indigenous vaccine developed by Bharat Biotech with the Indian Council for Medical Research (ICMR) will be used as a ‘backup’, only if the country needs additional doses to vaccinate large numbers of people, particularly given the possibility of an increase sudden triggered by the UK variant. And, unlike the …

NEW DELHI: Several Congressional leaders on Sunday raised questions about the approval process for Bharat Biotech’s Covid-19 vaccine, saying the “premature” step can prove to be “dangerous.” The government and the BJP responded vigorously to criticism from Congress, and BJP chief JP Nadda said the opposition party comes up with …

Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …

Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …

NEW DELHI: India approached the launch of its Covid-19 vaccination plan with the drug regulator’s committee of subject matter experts on Friday recommending emergency use authorization (EUA) for the Serum Institute of India’s “Covishield” , developed by the University of Oxford and AstraZeneca. The sources said the SEC’s recommendations come …

The Serum Institute of India, which is manufacturing and testing the Oxford / AstraZeneca coronavirus vaccine in the country, said Monday. awaited regulatory approval to take in a few days. Serum CEO Adar Poonawalla said the vaccine, called Covishield in India, should be licensed by January. “The emergency use authorization …

The Covid-19 vaccine developed by British pharmaceutical group AstraZeneca and the University of Oxford has produced a “winning formula” of efficacy, the company’s chief executive said Sunday. The vaccine, which is currently being evaluated by Britain’s independent drug regulator, provides “100% protection” against severe Covid disease that requires hospitalization, Pascal …

The drug regulator may give the Oxford COVID-19 vaccine a go-ahead next week. (Figurative) New Delhi: With preparations underway for a potential vaccine launch in January, India’s drug regulator is looking into the UK, which sources say may give the Oxford COVID-19 vaccine its go-ahead next week, ahead of decide …